OncoLink Cancer Treatment and Resources

Ovarian Cancer

 
Consolidation Radiotherapy After Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian Cancer
Reviewers: John Han-Chih Chang, MDSource: Gynecology Oncology 1999; Volume 72: pages 215 ? 219BackgroundOvarian cancer has become one of the most dreaded diseases to treat, because of the very poor survival in the epithelial types (the subject of...
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Authors: Armstrong DK, Bundy B, Wenzel L, et al. Source: New England Journal of Medicine 2006; 354:34–43. Background Ovarian Cancer (OC) is the leading cause of death among gynecologic cancers in the United States. The current...
Oral contraceptives and the risk of hereditary ovarian cancer
Reviewers: John Han-Chih Chang, MD and Kenneth Blank, MD Source: New England Journal of Medicine 339 (7): 424 IntroductionWomen with mutations to the BRCA1 or 2 genes are at increased risk forthe development of breast and ovarian cancer. The...
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
Authors: The ICON and AGO Collaborators Source: Lancet, Vol 361, 2099-2106, 2003 Background Ovarian cancer is the fourth most common cancer in women and among the most aggressive. Most women diagnosed with ovarian cancer will develop...
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Authors: Ozols RF, Bundy BN, Greer BE, et al. Source: JCO, Vol 21 (17), 1-7, 2003 Background Ovarian cancer is the fourth most common cancer in women and among the most aggressive A large proportion of patients will present with advanced...
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives
Reviewers: Li Liu, MD Source: American Journal of Epidemiology, Volume 152:233-241, (August) 2000Précis: Low-dose oral contraceptives appeared to be effective in reducing ovarian cancer riskIntroductionThe risk of ovarian cancer can be...
Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives. SHARE Study Group. Steroid Hormones and Reproductions
Reviewers: Li Liu, MD Source: American Journal of Epidemiology, Volume 152:233-241, (August) 2000Précis: Low-dose oral contraceptives appeared to be effective in reducing ovarian cancer riskIntroductionThe risk of ovarian cancer can be...
OncoLink I wish u knew...

Marianna talks about what makes a great oncology nurse and how the experience of caring for people with cancer is a rewarding career. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS